Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Cyberonics receives EU approval for expanded use of VNS

Dec. 5, 1997

Chiroscience files MAA for Chirocaine

Dec. 5, 1997

DuPont Merck develops novel CRF antagonists

Dec. 5, 1997

New tacrine analogue designated for further development

Dec. 5, 1997

New antipsychotic reported in development at Merck KGaA

Dec. 4, 1997

Profile of an mGluR2/mGluR3 agonist

Dec. 4, 1997

New mechanism involved in the anxiolytic effect of flesinoxan?

Dec. 4, 1997

Abecarnil reverses benzodiazepine resistance in mice

Dec. 4, 1997

NeoTherapeutics' cognition enhancer in preclinical testing

Dec. 4, 1997

Novo Nordisk licenses tiagabine to Sanofi

Dec. 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...